The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

The following is a summary of "Colorectal cancer incidence in steatotic liver disease (MASLD, MetALD, and ALD)," published in ...

Bariatric surgery reduces the progression to decompensated cirrhosis and the risk for major adverse liver outcomes, such as ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...

"The combination of MASLD, sarcopenia, and advanced fibrosis further worsened outcomes (HR 3.41). Additionally, metabolic dysfunction-associated alcohol-related liver disease (MetALD) and other ...

Discover how semaglutide aids weight loss in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD ...